These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 434198)

  • 1. Inhibition of glucagon-induced hepatic glucose production by indomethacin.
    Ganguli S; Sperling MA; Frame C; Christensen R
    Am J Physiol; 1979 Apr; 236(4):E358-65. PubMed ID: 434198
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin glucagon ration.
    Unger RH; Müller WA; Faloona GR
    Trans Assoc Am Physicians; 1971; 84():122-9. PubMed ID: 4950608
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential effects of oral, peripheral intravenous, and intraportal glucose on hepatic glucose uptake and insulin and glucagon extraction in conscious dogs.
    Ishida T; Chap Z; Chou J; Lewis R; Hartley C; Entman M; Field JB
    J Clin Invest; 1983 Aug; 72(2):590-601. PubMed ID: 6348094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indomethacin does not affect endogenous glucose production in type 2 diabetes mellitus.
    Pereira Arias AM; Bisschop PH; Ackermans MT; Endert E; Romijn JA; Sauerwein HP
    Horm Metab Res; 2001 Nov; 33(11):659-63. PubMed ID: 11733868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin as a mediator of hepatic glucose uptake in the conscious dog.
    Cherrington AD; Williams PE; Abou-Mourad N; Lacy WW; Steiner KE; Liljenquist JE
    Am J Physiol; 1982 Feb; 242(2):E97-101. PubMed ID: 7039339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon secretion and activity in the cobalt chloride-treated rat.
    Eaton RP
    Am J Physiol; 1973 Jul; 225(1):67-72. PubMed ID: 4714412
    [No Abstract]   [Full Text] [Related]  

  • 7. [Protective effect of indomethacin on alloxan-induced diabetes in rat].
    Xu WX; Yu JR
    Sheng Li Xue Bao; 1992 Apr; 44(2):202-8. PubMed ID: 1621111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulsatile hyperglucagonemia fails to increase hepatic glucose production in normal man.
    Paolisso G; Scheen AJ; Luyckx AS; Lefebvre PJ
    Am J Physiol; 1987 Jan; 252(1 Pt 1):E1-7. PubMed ID: 3544860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-independent effects of GLP-1 on canine liver glucose metabolism: duration of infusion and involvement of hepatoportal region.
    Dardevet D; Moore MC; Neal D; DiCostanzo CA; Snead W; Cherrington AD
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E75-81. PubMed ID: 15026303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of glucose production by indomethacin and pentoxifylline in healthy humans.
    Corssmit EP; Romijn JA; Endert E; Sauerwein HP
    Metabolism; 1996 Dec; 45(12):1458-65. PubMed ID: 8969277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological changes in circulating glucagon alter hepatic glucose disposition during portal glucose delivery.
    Holste LC; Connolly CC; Moore MC; Neal DW; Cherrington AD
    Am J Physiol; 1997 Sep; 273(3 Pt 1):E488-96. PubMed ID: 9316437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of glucocorticoids on hepatic sensitivity to insulin and glucagon in man.
    Dirlewanger M; Schneiter PH; Paquot N; Jequier E; Rey V; Tappy L
    Clin Nutr; 2000 Feb; 19(1):29-34. PubMed ID: 10700531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of glucagon to total parenteral nutrition (TPN) prevents hepatic steatosis in rats.
    Li SJ; Nussbaum MS; McFadden DW; Gapen CL; Dayal R; Fischer JE
    Surgery; 1988 Aug; 104(2):350-7. PubMed ID: 3135627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid changes in glucose metabolism following the administration of ethionine: its role in regulating hepatic protein synthesis.
    Lyon AW; Kisilevsky R
    Toxicol Pathol; 1986; 14(4):424-9. PubMed ID: 3544165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperglycemia per se (insulin and glucagon withdrawn) can inhibit hepatic glucose production in man.
    Liljenquist JE; Mueller GL; Cherrington AD; Perry JM; Rabinowitz D
    J Clin Endocrinol Metab; 1979 Jan; 48(1):171-5. PubMed ID: 422700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sequential infusions of glucagon and epinephrine on glucose turnover in the dog.
    Saccà L; Sherwin R; Felig P
    Am J Physiol; 1978 Sep; 235(3):E287-90. PubMed ID: 696823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic insulin and glucagon extraction after their augmented secretion in dogs.
    Röjdmark S; Bloom G; Chou MC; Jaspan JB; Field JB
    Am J Physiol; 1978 Jul; 235(1):E88-96. PubMed ID: 677314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose disposal during insulinopenia in somatostatin-treated dogs. The roles of glucose and glucagon.
    Shulman GI; Liljenquist JE; Williams PE; Lacy WW; Cherrington AD
    J Clin Invest; 1978 Aug; 62(2):487-91. PubMed ID: 670404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatotoxicity induced by diethylnitrosamine causes no significant disturbances of systemic glucose homeostasis in rats.
    Hwang DL; Lev-Ran A; Tay YC; De Meyts P
    Horm Metab Res; 1990 Sep; 22(9):462-6. PubMed ID: 2175290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of acute ethanol load on plasma immunoreactive insulin and glucagon.
    Jauhonen VP
    Horm Metab Res; 1978 May; 10(3):214-9. PubMed ID: 208941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.